Namibia

Opportunity
July 6, 2015

Formerly known as University Research South Africa (URSA), Aquity Innovations incorporates the legacy of URSA, while providing a platform to reemphasize our vision of an organization which is a hub for innovation in community- and patient - centered health and social development.

Resource
July 1, 2015

UNICEF estimates that more than 200 million children worldwide are unable to achieve their full potential because of inadequate nutrition, care, and opportunities to learn—resulting in a 20% loss of adult productivity. 

Resource
June 30, 2015

Poster presentation by the USAID-funded Building Local Capacity for Delivery of HIV Services in Southern Africa Project (BLC) at the 7th South African AIDS Conference in June 2015

Capacity development - so what? 

Resource
June 30, 2015

Poster presentation by the USAID-funded Building Local Capacity for Delivery of HIV Services in Southern Africa Project (BLC) at the 7th South African AIDS Conference in June 2015

Resource
June 30, 2015

Poster presentation by the USAID-funded Building Local Capacity for Delivery of HIV Services in Southern Africa Project (BLC) at the 7th South African AIDS Conference in June 2015.

The link between quality data and service provision 

Resource
June 30, 2015

Challenges in monitoring the HIV response 

Resource
June 30, 2015
Capacity development - so what?
 

Capacity development with civil society organizations (CSOs) providing HIV services has become an area of high donor investment to ensure cost-effectiveness and maximize the quality of services.

Resource
June 11, 2015
Namibia is a sparsely populated country, with 2.1 million people spread across 824,292 square kilometers. It has high HIV prevalence rates, estimated at 13.4% among adults aged 15–49 and 18.8% among pregnant women receiving antenatal care.
Resource
May 21, 2015

Tuberculosis (TB) remains one of the world’s deadliest communicable diseases. In 2013, an estimated nine million people developed TB and 1.5 million died from the disease. Africa accounts for 25% of the world’s TB cases, with the highest rates of cases and deaths relative to population.